Ghost Tree Capital, LLC Syndax Pharmaceuticals Inc Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 450,000 shares of SNDX stock, worth $5.89 Million. This represents 3.25% of its overall portfolio holdings.

Number of Shares

450,000

Previous 350,000 28.57%

Holding current value

$5.89 Million

Previous $7.19 Million 20.56%

% of portfolio

3.25%

Previous 2.93%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $1.79 Million - $2.48 Million	100,000 Added 28.57%	450,000 $8.66 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $3.76 Million - $4.76 Million	200,000 Added 133.33%	350,000 $7.19 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $2.96 Million - $3.69 Million	150,000 New	150,000 $3.57 Million
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $2.18 Million - $3.27 Million	-150,000 Reduced 42.86%	200,000 $2.9 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $483,750 - $557,750	25,000 Added 7.69%	350,000 $7.33 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $3.62 Million - $5.07 Million	175,000 Added 116.67%	325,000 $6.86 Million
Q4 2022 Feb 14, 2023	SELL	$20.64 - $26.24 $1.03 Million - $1.31 Million	-50,000 Reduced 25.0%	150,000 $3.82 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $462,750 - $619,750	-25,000 Reduced 11.11%	200,000 $4.81 Million
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $1.11 Million - $1.66 Million	-75,000 Reduced 25.0%	225,000 $3.91 Million
Q4 2021 Feb 16, 2022	SELL	$15.23 - $22.47 $4.19 Million - $6.18 Million	-275,000 Reduced 47.83%	300,000 $6.57 Million
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $4.16 Million - $5.94 Million	-300,000 Reduced 34.29%	575,000 $11 Million
Q2 2021 Aug 11, 2021	SELL	$13.42 - $25.18 $4.03 Million - $7.55 Million	-300,000 Reduced 25.53%	875,000 $15 Million
Q1 2021 May 14, 2021	SELL	$19.28 - $24.59 $3.37 Million - $4.3 Million	-175,000 Reduced 12.96%	1,175,000 $26.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $14 Million - $24.5 Million	925,000 Added 217.65%	1,350,000 $30 Million
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $3.21 Million - $4.2 Million	240,000 Added 129.73%	425,000 $6.27 Million
Q2 2020 Aug 14, 2020	SELL	$8.94 - $20.98 $581,100 - $1.36 Million	-65,000 Reduced 26.0%	185,000 $2.74 Million
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $1.66 Million - $3.01 Million	250,000 New	250,000 $2.74 Million

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Syndax Pharmaceuticals Inc Transaction History